Vulnerable populations: Better outcomes, better futures

  • CLINICAL MODELS ENHANCING QUALITY

When:

Wednesday 11 September

14:10–15:10

Session description:

This session highlights a variety of initiatives driving enhanced quality and safety in services delivered to vulnerable populations, women and in pediatric care.

Featured presentations:

  • The effective multidisciplinary action in the promotion, protection and support of exclusive breastfeeding in a hospital in the of Pará (Mrs Tainara Moraes)
  • Asthma avengers: Enhancing childhood asthma control and reducing emergencies through the implementation of the CDC’s EXHALE strategy (Dr Fawzyh Al Khadidi)
  • Improving maternal outcomes: A national multipayer coalition developing measures to support reduced perinatal complications and postpartum death (Dr Dana Gelb Safran)

Chair: Ms Barbara Walczyk Joers, President and CEO, Gillette Children’s Specialty Healthcare, USA

  • CLINICAL MODELS ENHANCING QUALITY

When:

Wednesday 11 September

14:10–15:10

Chair and Speakers

Ms Barbara Walczyk Joers

President and CEO, Gillette Children’s Specialty Healthcare, USA

Barbara Walczyk Joers has served as President and Chief Executive Officer at Gillette Children’s Specialty Healthcare in Minnesota, USA since 2013. As the United States’ first publicly funded hospital dedicated to serving children who have disabilities, Gillette Children’s today is an independent organization that provides subspecialized care to children who have complex, rare or traumatic conditions affecting the performance of an individual’s musculoskeletal and neurological systems.

With more than thirty years of healthcare experience, Ms Joers has a focus on strategic performance and organizational change management as well as health policy and advocacy. She has served in leadership roles in a variety of paediatric and adult healthcare settings, including academic healthcare centres, community health systems and independent children’s hospitals. Earlier in her career she also served at a professional services firm.

A recognized thought leader in healthcare, Ms Joers has been recognized as a transformative healthcare leader, one who appreciates and enjoys the complexities of navigating an ever-changing health care environment, while working to assure individuals’ health and well-being are the focus.

Ms Joers currently serves as the Chair of the Board of Trustees of Children’s Miracle Network Hospitals. She is also an active participant in other organizations including Health Evolution, Medical Alley, the International Hospital Federation, and the Minnesota Rare Disease Advisory Council.

Ms Joers studied acute care hospital administration at Marymount University (VA) and holds a Master’s in Health Services Management and Policy from George Washington University (W-DC).

Dr Fawzyh Al Khadidi

Pediatric Pulmonary Consultant, Al Hada Armed Forces Hospital, Saudi Arabia

Dr Fawzyh J. Al Khadidi is a Pediatric Pulmonary Consultant with license in Saudi Arabia. She possesses a Bachelor’s degree in Medicine and Surgery specialized in Pediatric and sub-specialized in Pulmonology. Furthermore, she has a Medical Healthcare Leadership Master from the Warwick University in UK.

In her current role as a Pediatric Pulmonologist for 6 years, she actively contributes to ensuring the alignment of patient safety and actively participates in quality improvement projects at the Armed Forces Hospitals Taif Region (AFHTR).

Dr Dana Gelb Safran

President and CEO, National Quality Forum; Chief Scientific Officer, The Joint Commission, USA

Dana Gelb Safran, ScD is President and CEO of the National Quality Forum (NQF), and the Chief Scientific Officer of The Joint Commission (TJC).

In addition to overseeing NQF’s longstanding function as steward for the U.S. portfolio of healthcare quality measures, Dr Safran is leading the expansion of NQF’s products and services to advance healthcare quality, outcomes, equity, and affordability – including new products offered in partnership with the Joint Commission.

Dr Safran is internationally recognized with a unique blend of accomplishment in business and academia. A central feature of her work has been combining the science of quality measurement with the art of its use to drive change in the quality, outcomes, and affordability of care.

Dr Safran’s prior roles include serving as a Senior Executive at Blue Cross Blue Shield of Massachusetts, where she was a Lead Architect of their Alternative Quality Contract: widely credited with catalyzing the value-based payment movement among public and private payers. She was also a Founding Member of the Executive Team at Haven: a joint venture of Amazon, Berkshire Hathaway, and JP Morgan Chase to achieve better health outcomes, care experiences, and costs of care through innovation in care delivery, benefit design, and purchasing.

Dr Safran is on the faculty of the Tufts University School of Medicine and, from 2017 to 2023, she served as a Commissioner of the Medicare Payment Advisory Commission. She holds a BA in Biology and Government from Wesleyan University and an ScM and ScD in Health Policy and Management from the Harvard School of Public Health.

Mrs Tainara Moraes

Nurse, Yutaka Takeda Hospital, Brazil

Nurse, graduated from Faculdade Estácio de Sá de Goiás (FESGO) since 2015. Specialist in occupational nursing, gynecology and obstetrics. She has more than 7 years of experience as a teacher collaborating on technical and higher nursing courses. She is currently in charge of the Continuing Education Center and is president of the Maternal and Child Multidisciplinary Care Committee (CAMMI) at Yutaka Takeda hospital.